BNP Paribas’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$46.9M Buy
69,186
+5,594
+9% +$3.32M 1.13% 22
2026
Q2
$32M Sell
63,592
-8,103
-11% -$3.89M 0.87% 26
2026
Q1
$34.6M Buy
71,695
+1,939
+3% +$1.05M 1.1% 21
2025
Q4
$40.5M Buy
69,756
+5,799
+9% +$3.28M 1.16% 20
2025
Q3
$30M Sell
63,957
-718
-1% -$334K 0.9% 29
2025
Q2
$26.3M Buy
64,675
+5,825
+10% +$2.44M 0.85% 32
2025
Q1
$29.3M Buy
58,850
+7,295
+14% +$3.95M 1.22% 23
2024
Q4
$26.8M Buy
51,555
+5,556
+12% +$3.05M 0.16% 29
2024
Q3
$28.4M Buy
45,999
+740
+2% +$438K 1.18% 26
2024
Q2
$24.9M Sell
45,259
-579
-1% -$332K 1.25% 25
2024
Q1
$26.4M Buy
+45,838
New +$25.7M 1.23% 25

Other funds holding TMO

BNP Paribas's TMO Position: Q3 2026 in Review

BNP Paribas increased its Thermo Fisher Scientific (TMO) stake by 8.8% in Q3 2026, buying an estimated $3.32M and bringing the position to 69,186 shares worth $46.9M. The position accounts for 1.13% of the portfolio, ranked #22.

BNP Paribas first reported a position in TMO in Q1 2024 and has held it in 11 quarters since. 2,450 funds tracked by Wall St. Rank hold TMO as of Q3 2026.

  • BNP Paribas held 69,186 shares of Thermo Fisher Scientific worth $46.9M as of Q3 2026.
  • BNP Paribas bought 5,594 Thermo Fisher Scientific shares in Q3 2026, an estimated $3.32M.
  • Thermo Fisher Scientific made up 1.13% of BNP Paribas's portfolio in Q3 2026, its #22 holding.
  • BNP Paribas first reported a position in Thermo Fisher Scientific in Q1 2024 and has held it in 11 quarters since.
  • 2,450 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.

Based on BNP Paribas's 13F filing for Q3 2026, filed 12 Nov 2026.